These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1084762)

  • 1. Human plasma kallikreins and their inhibition by amidino compounds.
    Asghar SS; Meijlink FC; Pondman KW; Cormane RH
    Biochim Biophys Acta; 1976 Jun; 438(1):250-64. PubMed ID: 1084762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):11-22. PubMed ID: 4974623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and properties of rat stomach kallikrein.
    Uchida K; Niinobe M; Kato H; Fujii S
    Biochim Biophys Acta; 1980 Aug; 614(2):501-10. PubMed ID: 6157423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of trypsin inhibitor of a peptide-protein nature on kallikreins from human and rabbit blood stream].
    Paskhina TS; Krinskaia AV; Zykova VP
    Biokhimiia; 1975; 40(2):302-9. PubMed ID: 1081887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification of plasma and tissue kallikreins in psoriatic epidermis.
    Hibino T; Izaki S; Kimura H; Izaki M; Kon S
    J Invest Dermatol; 1988 Apr; 90(4):505-10. PubMed ID: 3351334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on urinary kallikreins. I. Purification and characterization of human urinary kallikreins.
    Matsuda Y; Miyazaki K; Moriya H; Fujimoto Y; Hojima Y; Moriwaki C
    J Biochem; 1976 Oct; 80(4):671-9. PubMed ID: 1087637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat stomach kallikrein: its purification and properties.
    Uchida K; Yokoshima A; Niinobe M; Kato H; Fujii S
    Adv Exp Med Biol; 1979; 120A():291-303. PubMed ID: 495318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization.
    Newball HH; Berninger RW; Talamo RC; Lichtenstein LM
    J Clin Invest; 1979 Aug; 64(2):457-65. PubMed ID: 37257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat urinary kallikrein: purification and properties.
    Silva E; Diniz CR; Mares-Guia M
    Biochemistry; 1974 Oct; 13(21):4304-10. PubMed ID: 4415477
    [No Abstract]   [Full Text] [Related]  

  • 10. Basophil kallikrein of anaphylaxis (BK-A)--purification and characterization.
    Newball HH; Berninger RW; Talamo RC; Lichtenstein LM
    Adv Exp Med Biol; 1979; 120B():233-47. PubMed ID: 517236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells and components of the kallikrein-kinin system.
    Ryan US; Ryan JW; Habliston DL; Pena GA
    Adv Exp Med Biol; 1979; 120B():275-86. PubMed ID: 229704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mite protease (Df-protease) with protease inhibitors.
    Matsushima A; Kodera Y; Ozawa S; Kobayashi M; Maeda H; Inada Y
    Biochem Int; 1992 Dec; 28(4):717-23. PubMed ID: 1282814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glass activated kallikrein from human plasma.
    Henriques OB; Allan L
    Biochem Pharmacol; 1972 Dec; 21(23):3163-9. PubMed ID: 4650638
    [No Abstract]   [Full Text] [Related]  

  • 14. Human plasma kallikrein. Purification and preliminary characterization.
    Sampaio C; Wong SC; Shaw E
    Arch Biochem Biophys; 1974 Nov; 165(1):133-9. PubMed ID: 4474835
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of commercial polyvalent proteinase inhibitors. Comparative analysis of their effect on kallikreins from different sources and trypsin].
    Iarovaia GA; Dotsenko VL; Agapova EI; Stepanian EP
    Vopr Med Khim; 1980; 26(6):832-7. PubMed ID: 6161484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein inhibitors in rat plasma.
    Hojima Y; Isobe M; Moriya H
    J Biochem; 1977 Jan; 81(1):37-46. PubMed ID: 14935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of porcine glandular kallikreins by structurally homologous proteinase inhibitors of the Kunitz (Trasylol) type. Significance of the basic nature of amino acid residues in subside positions for kallikrein inhibition.
    Dietl T; Huber C; Geiger R; Iwanaga S; Fritz H
    Hoppe Seylers Z Physiol Chem; 1979 Jan; 360(1):67-71. PubMed ID: 761847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of covalent binding of aprotinin with a polysaccharide carrier on its inhibition of kallikrein from human plasma, porcine pancreatic kallikrein and trypsin].
    Larionova NI; Makevnina LG; Nartikova VF; Paskhina TS
    Biokhimiia; 1987 May; 52(5):825-31. PubMed ID: 2439135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.
    Imamura T; Yamamoto T; Kambara T
    Am J Pathol; 1984 Apr; 115(1):92-101. PubMed ID: 6424481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aromatic diamidines with central alpha-oxyalkane or alpha, omega-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation process.
    Geratz JD; Cheng MC; Tidwell RR
    J Med Chem; 1975 May; 18(5):477-81. PubMed ID: 1171238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.